Parallax Volatility Advisers
NVRO

Parallax Volatility Advisers’s NEVRO CORP. NVRO Stock Holding History

Parallax Volatility Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,500
Closed -$574K – 3904
2015
Q4 		$574K Buy
+8,500
New +$455K ﹤0.01% 1486

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parallax Volatility Advisers's NVRO Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 632 shares — an estimated $88K sold.

Parallax Volatility Advisers first reported a position in NVRO in Q4 2015 and held it in 6 quarters. The position peaked at $293K in Q4 2017. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 632 NEVRO CORP. shares in Q4 2020, an estimated $88K.
  • Parallax Volatility Advisers first reported a position in NEVRO CORP. in Q4 2015 and held it in 6 quarters.
  • Parallax Volatility Advisers's NEVRO CORP. position peaked at $293K in Q4 2017.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.